State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Hidradenitis Suppurativa (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Pressure Injury (2)Cardiovascular Diseases (2)Overweight (2)Obesity (2)
NCT07158658 N/A
Recruiting
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for ...
Condition
Pressure Injury
Enrollment
10 pts
Location
United States
Sponsor
NuScience Medical Biologics, L
NCT03747458 Phase 3
Recruiting
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Condition
Bilateral Nasal Polyposis
Enrollment
72 pts
Location
United States, Argentina
Sponsor
Optinose US Inc.
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT04583514 N/A
Recruiting
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
Condition
Overweight and Obesity
Enrollment
58 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT06615479 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimen...
Condition
Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment
440 pts
Location
United States, Argentina, Australia
Sponsor
Juno Therapeutics, Inc., a Bri
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT06972446 Phase 2
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Ar...
Condition
Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, Canada, Czechia
Sponsor
AbbVie
Page 6 of 6 — 137 trials total